Boehringer Ingelheim, a leading research-driven biopharmaceutical company in Vietnam, is proudly commemorating the 15th anniversary of its animal health business.
|Boehringer Ingelheim's animal health marks 15 years of success in Vietnam
This milestone was celebrated with a special event attended by nearly 190 customers, highlighting the company’s commitment to customer-centricity and collaboration in delivering first-in-class innovative solutions for the livestock and companion animal segments.
Since its establishment in 2008, the animal health business in Vietnam has forged strong relationships and partnerships with its customers and business partners.
Armin Wiesler, country managing director and head of Animal Health, Regional Operating Unit ASEAN, Korea, Australia, and New Zealand said, “This anniversary serves as a testament to the unwavering trust and support of our customers and business partners. Their collaboration has been instrumental in our journey towards sustainable growth and enhanced healthcare for animals in Vietnam.”
Driven by the purpose of bringing “Value through innovation,” Boehringer Ingelheim has launched more than 40 animal health products over the past 15 years in Vietnam. Our portfolio includes vaccines, parasite-control products, and therapeutics complemented by diagnostics and monitoring platforms to help protect and treat disease in pets and livestock.
Many of them became best-in-class brands, such as Parasiticides of the Frontline and Nexgard family as well as Recombitec vaccines in pets, Ingelvac PRRS MLV, Ingelvac CircoFLEX, Ingelvac MycoFLEX and the Enterisol vaccine range in swine, Vaxxitek, Newxxitec, PREVEXXION RN and Gallimune range of poultry vaccines.
|Armin Wiesler, country managing director and head of Animal Health, Regional Operating Unit ASEAN, Korea, Australia, and New Zealand
Torsten Hardge, director of Animal Health, Boehringer Ingelheim Vietnam said, “Innovation and our expertise in animal health are at the core of Boehringer Ingelheim’s business activities globally and in Vietnam. We are passionate about bringing cutting-edge innovations to our customers, and integrating smart digital technologies like Soundtalks – which supports early detection of respiratory disease in pigs and introducing e-commerce solutions for convenient access to our pet products. As a result, we are positively impacting the lives of animals and humans in Vietnam.”
Apart from the relentless effort to bring innovative pharmaceutical solutions for humans and animals, Boehringer Ingelheim commits to contributing its expertise and heritage to make meaningful advances towards rabies elimination, especially in under-served communities.
Through STOP Rabies programme in Vietnam, in collaboration with the Department of Agriculture and Rural Development in Duc Hue District People's Committee, 20,000 dogs and cats have been vaccinated against rabies since 2021 and are on track to eliminate dog-mediated rabies in the Long An province by 2025.
In addition, 1,000 students have been educated about rabies and dog bite prevention, in efforts to raise awareness and knowledge about rabies in communities, especially among children.
Working towards to carbon neutrality in our company operations by 2030, Boehringer Ingelheim Vietnam will continue to reduce our carbon footprint and operational waste of our solutions to mitigate the environmental impact of the business.
|Boehringer Ingelheim strengthens commitment to transforming lives in Vietnam
The Vietnamese market holds significant potential as compared to other Southeast Asian countries and the region. Cyndy B. Galimpin, general manager of Boehringer Ingelheim Vietnam, discussed the company's accomplishments and its future with VIR’s Bich Ngoc.
|Work continues on a rabies-free future
Germany's Boehringer Ingelheim, along with Eco-Business, unveiled its 'STOP Rabies' whitepaper at the Federation of Asian Veterinary Association (FAVA) Congress on November 4 in Malaysia.
|Low vaccination rates and dog smuggling aiding transmission in Vietnam
Vietnam’s national rabies control efforts have been proving to be incrementally effective, yet some risks still persist due to free-roaming animals, some lack of awareness, the dog meat trade, and a low proportion of vaccinated pets.